Nuveen Asset Management, LLC Arvinas, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 202,372 shares of ARVN stock, worth $4.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

202,372

Previous 296,017 31.64%

Holding current value

$4.98 Million

Previous $12.2 Million 55.91%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$24.46 - $40.4 $2.29 Million - $3.78 Million	-93,645 Reduced 31.64%	202,372 $5.39 Million
Q1 2024 May 13, 2024	SELL	$36.38 - $52.31 $2.26 Million - $3.25 Million	-62,162 Reduced 17.36%	296,017 $12.2 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $294,158 - $877,500	20,730 Added 6.14%	358,179 $14.7 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $1.8 Million - $2.59 Million	91,721 Added 37.33%	337,449 $6.63 Million
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $2.61 Million - $3.77 Million	120,034 Added 95.5%	245,728 $6.1 Million
Q1 2023 May 15, 2023	SELL	$26.15 - $37.26 $250,307 - $356,652	-9,572 Reduced 7.08%	125,694 $3.43 Million
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $1.16 Million - $2.04 Million	-35,677 Reduced 20.87%	135,266 $4.63 Million
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $150,145 - $207,952	-3,586 Reduced 2.05%	170,943 $7.61 Million
Q2 2022 Aug 15, 2022	SELL	$36.01 - $74.24 $1.4 Million - $2.89 Million	-38,974 Reduced 18.25%	174,529 $7.35 Million
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $3.64 Million - $4.93 Million	-60,462 Reduced 22.07%	213,503 $14.2 Million
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $5.35 Million - $7.82 Million	-81,279 Reduced 22.88%	273,965 $22.5 Million
Q3 2021 Nov 12, 2021	SELL	$73.2 - $107.87 $2.3 Million - $3.4 Million	-31,477 Reduced 8.14%	355,244 $29.2 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $806,523 - $1.12 Million	13,342 Added 3.57%	386,721 $29.8 Million
Q1 2021 May 17, 2021	BUY	$58.19 - $91.37 $3.59 Million - $5.63 Million	61,620 Added 19.77%	373,379 $24.7 Million
Q4 2020 May 17, 2021	SELL	$20.19 - $84.93 $235,980 - $992,661	-11,688 Reduced 3.61%	311,759 $26.5 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $781,433 - $3.29 Million	38,704 Added 13.59%	323,447 $27.5 Million
Q3 2020 Nov 16, 2020	SELL	$22.99 - $36.34 $226,819 - $358,530	-9,866 Reduced 3.35%	284,743 $6.72 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $1.38 Million - $2.61 Million	46,024 Added 18.51%	294,609 $9.88 Million
Q1 2020 May 14, 2020	BUY	$33.0 - $54.5 $1.04 Million - $1.71 Million	31,373 Added 14.44%	248,585 $10 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $563,073 - $1.62 Million	36,587 Added 20.26%	217,212 $8.93 Million
Q3 2019 Nov 14, 2019	SELL	$21.55 - $27.61 $845,255 - $1.08 Million	-39,223 Reduced 17.84%	180,625 $3.89 Million
Q2 2019 Aug 15, 2019	BUY	$15.96 - $23.8 $3.51 Million - $5.23 Million	219,848 New	219,848 $4.83 Million

Others Institutions Holding ARVN

# of Institutions

224

Shares Held

68.7M

Call Options Held

166K

Put Options Held

31.3K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.31B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Arvinas, Inc. Transaction History